US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Snack Innovations Inc. Conducts Voluntary Recall on a Limited Quantity of Drizzilicious Mini Rice Cakes 4oz & .74oz and Popcorn 3.6oz Products in the U.S. Due to Undeclared Peanut Allergen on Packaging

      Summary Company Announcement Date: January 25, 2023 FDA Publish Date: … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / ETHEX Corporation Issues Nationwide Voluntary Recall of Products (January 28)

ETHEX Corporation Issues Nationwide Voluntary Recall of Products (January 28)

January 29, 2009 By The FDA Leave a Comment

Click Here for previous ETHEX recalls

ETHEX CORPORATION, A SUBSIDIARY OF KV PHARMACEUTICAL (NYSE: KVA/KVB), IS ISSUING, AS PREVIOUSLY DISCLOSED BY KV PHARMACEUTICAL COMPANY ON JANUARY 26, 2009, A NATIONWIDE VOLUNTARY RECALL OF THE PRODUCTS IDENTIFIED BELOW (ALL LOTS WITHIN THEIR EXPIRATION DATES) AT A WHOLESALE OR A RETAIL LEVEL AS A PRECAUTIONARY MEASURE BECAUSE THEY MAY HAVE BEEN MANUFACTURED UNDER CONDITIONS THAT DID NOT SUFFICIENTLY COMPLY WITH CURRENT GOOD MANUFACTURING PRACTICES (CGMPS). SOME OF THESE PRODUCTS HAVE HAD SPECIFIC LOTS RECALLED EARLIER DUE TO DEFECTS FOUND, INCLUDING OVERSIZED TABLETS DELIVERING HIGHER THAN LABELED DOSES.  THESE ADDITIONAL PRODUCTS ARE BEING REMOVED TO ASSURE THAT NO OTHER DEFECTIVE PRODUCTS REMAIN IN THE MARKETPLACE.

PATIENTS WHO MAY HAVE THESE MEDICINES IN THEIR POSSESSION SHOULD CONTINUE TO TAKE THEM IN ACCORDANCE WITH THEIR PRESCRIPTIONS, AS THE RISK OF SUDDENLY STOPPING NEEDED MEDICATION MAY PLACE PATIENTS AT RISK.  PATIENTS SHOULD CONTACT THEIR PHYSICIAN OR HEALTHCARE PROVIDER IF THEY HAVE EXPERIENCED ANY PROBLEMS THAT MAY BE RELATED TO TAKING OR USING THESE PRODUCTS, OR TO OBTAIN REPLACEMENT MEDICATIONS OR PRESCRIPTIONS.    PRODUCTS RECALLED TO WHOLESALE LEVEL:

AMLODIPINE BESYLATE TABLETS, 10MG (58177-538-26 & 538-11) AMLODIPINE BESYLATE TABLETS, 2.5MG (58177-536-26) AMLODIPINE BESYLATE TABLETS, 5MG (58177-537-26, 537-07 & 537-11) BENAZEPRIL HCL TABLETS, 10MG (58177-342-04 & 342-08) BENAZEPRIL HCL TABLETS, 20MG (58177-343-04 & 343-08) BENAZEPRIL HCL TABLETS, 40MG, (58177-344-04 & 344-08) BENAZEPRIL HCL TABLETS, 5MG (58177-341-04) BENZONATATE CAPSULES, 100MG (58177-091-04 & 091-08) BENZONATATE CAPSULES, 200MG (58177-092-04 & 092-08) BROMFENEX ER CAPSULES (58177-019-04) BROMFENEX PD ER CAPSULES (58177-020-04) BUSPIRONE HCL TABLETS, 10MG (58177-265-04 & 265-08) BUSPIRONE HCL TABLETS, 15MG (58177-309-04 & 309-08) BUSPIRONE HCL TABLETS, 5MG (58177-264-04 & 264-08)

CODEINE PHOSPHATE/GUAIFENESIN TABLETS, 10MG (58177-223-04) DEXTROAMPHETAMINE SULFATE TABLETS, 10MG (58177-312-04) DEXTROAMPHETAMINE SULFATE TABLETS, 5MG (58177-311-04) DEXTROAMPHETAMINE TABLETS, 10MG (58177-312-04) DILTIAZEM HC1 CAPSULES, 120MG (58177-061-11) DILTIAZEM HC1 CAPSULES, 120MG (58177-061-19 & 061-26) DILTIAZEM HC1 CAPSULES, 180MG (58177-062-09 & 062-11) DILTIAZEM HC1 CAPSULES, 180MG (58177-062-19 & 062-26) DILTIAZEM HC1 CAPSULES, 240MG (58177-063-09 & 063-11) DILTIAZEM HC1 CAPSULES, 240MG (58177-063-19 & 063-26) DILTIAZEM HC1 CAPSULES, 300MG (58177-064-19 & 064-26) DILTIAZEM HC1 CAPSULES, 360MG (58177-065-09 & 065-11) DILTIAZEM HC1 CAPSULES, 360MG (58177-065-19 & 065-26) DILTIAZEM HC1 CAPSULES, 420MG (58177-066-09 & 066-11) DILTIAZEM HC1 CAPSULES, 420MG (58177-066-19 & 066-26) DISOPYRAMIDE PHOSPHATE ER CAPSULES, 150MG (58177-002-04) DOXAZOSIN MESYLATE TABLETS, 1MG (58177-266-04 & 266-08) DOXAZOSIN MESYLATE TABLETS, 2MG (58177-267-04 & 267-08) DOXAZOSIN MESYLATE TABLETS, 4MG (58177-268-04 & 268-08) DOXAZOSIN MESYLATE TABLETS, 8MG (58177-269-04 & 269-08) ETHEDENT CHEWABLE TABLETS, .25MG (58177-432-40) ETHEDENT CHEWABLE TABLETS, .5MG (58177-433-40 & 433-09) ETHEDENT CHEWABLE TABLETS, 1MG (58177-434-40 & 434-09) ETHEXDERM BPW-10, 10% (58177-929-65) ETHEXDERM BPW-5, 5%    (58177-928-65) ETHEZYME 650 (58177-868-02) ETHEZYME 830 PAPAIN-UREA (58177-816-02) ETHEZYME PAPAIN-UREA (58177-804-02) ETH-OXYDOSE CONCENTRATED SOLUTION (58177-914-04 & 914-56) GUAIFENEX DM ER TABLETS (58177-213-04) GUAIFENEX GP ER TABLETS (58177-373-04) GUAIFENEX PSE 120 ER TABLETS (58177-208-04) GUAIFENEX PSE 60 ER TABLETS (58177-214-04) GUAIFENEX PSE 80 TABLETS (58177-413-04) GUAIFENEX PSE 85 TABLETS (58177-478-04) HISTA-VENT DA TABLETS (58177-227-04) HISTA-VENT PSE TABLETS (58177-426-04) HISTINEX HC LIQUID (58177-877-07 & 877-12) HISTINEX PV LIQUID (58177-883-07) HYDROCODONE BITARTRATE & ACETAMINOPHEN LIQUID     (58177-909-07) HYDROCODONE BITARTRATE/GUAIFENESIN LIQUID (58177-881-07) HYDROCORTISONE AND IODOQUINOL CREAM, 1%   (58177-803-02) HYDROQUINONE 4% CREAM W/SS, 1OZ. (58177-802-02) HYDROQUINONE 4% CREAM, 1OZ. (58177-801-02) HYDRO-TUSSIN CBX LIQUID (58177-924-07) HYDRO-TUSSIN DHC SYRUP (58177-926-07) HYDRO-TUSSIN DM LIQUID (58177-906-07) HYDRO-TUSSIN EXP LIQUID (58177-927-07) HYDROTUSSIN HC SYRUP (58177-915-07) HYDRO-TUSSIN LIQUID (58177-890-07) HYDRO-TUSSIN XP LIQUID (58177-916-07) HYOSCYAMINE ORALLY DISINTEGRATING TABLETS, .125MG (58177-423-04) HYOSCYAMINE SUBLINGUAL TABLETS, .125MG (58177-255-04) HYOSCYAMINE SULFATE ER   TABLETS, .375MG (58177-237-04) HYOSCYAMINE SULFATE ER CAPSULES, .375MG (58177-017-04) HYOSCYAMINE SULFATE ORAL TABLETS, .125MG (58177-274-04) ISOSORBIDE MONONITRATE ER TABLETS, 120MG (58177-201-04)

ISOSORBIDE MONONITRATE ER TABLETS, 30MG (58177-222-04, 222-08 & 222-11) ISOSORBIDE MONONITRATE ER TABLETS, 60MG (58177-238-04, 238-08 & 238-11) MEPERIDINE/PROMETHAZIDNE CAPSULES (58177-027-04) MORPHINE INVEAMP, 20MG X 1ML (58177-886-56) MORPHINE INVEAMP, 5MG/.25ML (58177-888-80) MORPHINE SULFATE CONCENTRATED ORAL SOLUTION 20MG/1ML   (58177-886-01, 886-03 &886-05) MORPHINE SULFATE CONCENTRATED ORAL SOLUTION, 20MG/1ML   (58177-886-57) MORPHINE SULFATE ER TABLETS, 100MG (58177-340-04) MORPHINE SULFATE ER TABLETS, 15MG (58177-310-04) MORPHINE SULFATE ER TABLETS, 200MG (58177-380-04) MORPHINE SULFATE ER TABLETS, 30MG (58177-320-04) MORPHINE SULFATE ER TABLETS, 60MG (58177-330-04) MORPHINE SULFATE IR TABLETS, 15MG (58177-313-04) MORPHINE SULFATE IR TABLETS, 30MG (58177-314-04) NITROQUICK SUBLINGUAL TABLETS, .3MG (58177-323-04) NITROQUICK SUBLINGUAL TABLETS, .4MG (58177-324-18 & 324-04) NITROQUICK SUBLINGUAL TABLETS, .6MG (58177-325-04) NYSTATIN TOPICAL POWDER,  USP 15 GRAMS (58177-839-45) NYSTATIN TOPICAL POWDER, USP 30 GRAMS (58177-839-46) NYSTATIN TOPICAL POWDER, USP 60 GRAMS (58177-839-61) ONDANSETRON ORALLY DISINTEGRATING TABLETS, 4MG (58177-363-22) ONDANSETRON ORALLY DISINTEGRATING TABLETS, 8MG (58177-364-22 & 364-56) OXYCODONE HCL CAPSULES, 5MG   (58177-041-04 & 041-11) OXYCODONE HCL IR TABLETS,  10MG (58177-461-04) OXYCODONE HCL IR TABLETS,  15MG, (58177-445-04) OXYCODONE HCL IR TABLETS,  20MG (58177-462-04) OXYCODONE HCL IR TABLETS, 30MG (58177-446-04) OXYCODONE HCL IR TABLETS, 5MG (58177-625-04 & 625-11) PANGESTYME CN 20 (58177-030-04) PANGESTYME CN10   (58177-029-04) PANGESTYME EC 100 (58177-031-04) PANGESTYME EC 250   (58177-031-06) PANGESTYME MT16  (58177-028-04) PANGESTYME UL12  (58177-048-04) PANGESTYME UL18  (58177-049-04) PANGESTYME UL20   (58177-050-04) PHENAVENT CAPSULES (58177-078-19) PHENAVENT D TABLETS (58177-444-04) PHENAVENT LA CAPSULES (58177-095-19) PHENAVENT PED CAPSULES (58177-079-04) PLARETASE 800  (58177-416-04 & 416-08) POTASSIUM CHLORIDE ER CAPSULES, 10MEQ (58177-001-04, 001-08, 001-09, & 001-11) POTASSIUM CHLORIDE ER CAPSULES, 8MEQ (58177-677-04 & 677-08) POTASSIUM CHLORIDE ER TABLETS, 20MEQ (58177-202-04, 202-08, 202-09 & 202-11) PREDNISOLONE SODIUM ORAL SOLUTION (58177-932-05) PREDNISOLONE SYRUP 15MG/5ML  (58177-910-05 & 910-07) PREDNISOLONE SYRUP 5MG/5ML (58177-912-03) PROPAFENONE HCL TABLETS, 150MG (58177-331-04 & 331-11) PROPAFENONE HCL TABLETS, 225MG (58177-332-04) PROPAFENONE HCL TABLETS, 300MG (58177-333-04) PSEUDOVENT 400 CAPSULES (58177-096-04) PSEUDOVENT CAPSULES (58177-045-04) PSEUDOVENT PED CAPSULES (58177-046-04) TRI-VENT DM SYRUP (58177-925-07) TRI-VENT DPC LIQUID (58177-923-07) TRI-VENT HC LIQUID (58177-920-07)

PRODUCTS RECALLED TO RETAIL PHARMACY LEVEL:

HYDROMORPHONE HCL TABLETS, 2MG (58177-620-04 & 620-11) HYDROMORPHONE HCL TABLETS, 4MG (58177-621-04 & 621-11) HYDROMORPHONE HCL TABLETS, 8MG (58177-449-04) METOPR
OLOL SUCCINATE ER TABLETS, 50MG (58177-369-04, 369-09 & 369-11) METOPROLOL SUCCINATE ER TABLETS, 100MG (58177-368-04, 368-09 & 368-11) METOPROLOL SUCCINATE ER TABLETS, 25MG (58177-293-04, 293-09 & 293-11) METOPROLOL SUCCINATE ER TABLETS, 200MG (58177-358-04, 358-09 & 358-11)

ANY WHOLESALE OR RETAIL CUSTOMER INQUIRIES RELATED TO THIS ACTION SHOULD BE ADDRESSED TO ETHEX CUSTOMER SERVICE AT 1-800-748-1472, FAXED TO ETHEX CUSTOMER SERVICE AT 314-646-3788, OR E-MAILED TO [email protected] REPRESENTATIVES ARE AVAILABLE MONDAY THROUGH FRIDAY, 8 AM TO 5 PM CST. ETHEX CORPORATION HAS INITIATED RECALL NOTIFICATIONS TO WHOLESALERS (AND TO RETAILERS FOR HYDROMORPHONE HCL AND METOPROLOL SUCCINATE ONLY) NATIONWIDE WHO RECEIVED ANY INVENTORY OF THE RECALLED PRODUCTS WITH INSTRUCTIONS FOR RETURNING THE RECALLED PRODUCTS.    PATIENTS WITH QUESTIONS ABOUT THE RECALL SHOULD CALL THE TELEPHONE NUMBER ABOVE, OR CONTACT THEIR HEALTHCARE PROVIDERS.

THIS RECALL IS BEING CONDUCTED WITH THE KNOWLEDGE OF THE U.S. FOOD AND DRUG ADMINISTRATION (FDA). AT THIS TIME, THE COMPANY IS UNABLE TO DETERMINE WHEN DISTRIBUTION OF THESE PRODUCTS WILL RESUME. ANY ADVERSE REACTIONS EXPERIENCED WITH THE USE OF THESE PRODUCTS SHOULD ALSO BE REPORTED TO THE FDA’S MEDWATCH PROGRAM BY PHONE AT 1-800-FDA-1088, BY FAX AT 1-800-FDA-0178, BY MAIL AT MEDWATCH, FDA, 5600 FISHERS LANE, ROCKVILLE, MD 20852-9787, OR ON THE MEDWATCH WEBSITE AT WWW.FDA.GOV/MEDWATCH.

THE RECALL ANNOUNCEMENT IS POSTED ON WWW.KVPHARMA.COM.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Snack Innovations Inc. Conducts Voluntary Recall on a Limited Quantity of Drizzilicious Mini Rice Cakes 4oz & .74oz and Popcorn 3.6oz Products in the U.S. Due to Undeclared Peanut Allergen on Packaging

January 25, 2023 By The FDA

Almondy is Initiating a Recall of a Limited Quantity of Almondy Chocolate Cake with Daim 14.1oz

January 25, 2023 By The FDA

SkinnyDipped® Issues Allergy Alert on Undeclared Peanuts in a Limited Number of SkinnyDipped® Dark Chocolate Nut Products

January 20, 2023 By The FDA

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Vaenait Baby Recalls Children’s Robes Due to Violation of Federal Flammability Standards and Burn Hazard

January 18, 2023 By The CPSC

Vanessa Fire Tables Recalled Due to Fire Hazard; Imported by Ove Decors

January 18, 2023 By The CPSC

Children’s Pajama Sets Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Manufactured by Selfie Craft Company

January 18, 2023 By The CPSC

NewCosplay Children’s Sleepwear Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Imported by Hainan Chong Yu Industrial; Sold Exclusively at Amazon.com

January 18, 2023 By The CPSC

Meguiar’s Recalls Headlight Sealant Due to Failure to Meet Child Resistant Packaging Requirements; Risk of Poisoning

January 18, 2023 By The CPSC

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

NewCosplay Children’s Sleepwear Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Imported by Hainan Chong Yu Industrial; Sold Exclusively at Amazon.com

January 18, 2023 By The CPSC

Meguiar’s Recalls Headlight Sealant Due to Failure to Meet Child Resistant Packaging Requirements; Risk of Poisoning

January 18, 2023 By The CPSC

NewCosplay Children’s Sleepwear Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Imported by Shanghai Xunao Elevator; Sold Exclusively at Amazon.com

January 18, 2023 By The CPSC

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Snack Innovations Inc. Conducts Voluntary Recall on a Limited Quantity of Drizzilicious Mini Rice Cakes 4oz & .74oz and Popcorn 3.6oz Products in the U.S. Due to Undeclared Peanut Allergen on Packaging
  • Almondy is Initiating a Recall of a Limited Quantity of Almondy Chocolate Cake with Daim 14.1oz
  • SkinnyDipped® Issues Allergy Alert on Undeclared Peanuts in a Limited Number of SkinnyDipped® Dark Chocolate Nut Products
  • Lifetime Brands Recalls Hot Chocolate Pots Due to Fire Hazard; Sold Exclusively at Williams-Sonoma
  • Sakar International Recalls Multi-Purpose Helmets Due to Risk of Head Injury
  • Vaenait Baby Recalls Children’s Robes Due to Violation of Federal Flammability Standards and Burn Hazard
  • Vanessa Fire Tables Recalled Due to Fire Hazard; Imported by Ove Decors
  • Children’s Pajama Sets Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Manufactured by Selfie Craft Company
  • NewCosplay Children’s Sleepwear Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Imported by Hainan Chong Yu Industrial; Sold Exclusively at Amazon.com
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in